At the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, major shifts in dermatology became clear — and they’re already starting to change how we treat patients.
In this episode of SkinScope, Dr Sandra Jerkovic Gulin and Dr George Kravvas break down the most important clinical updates in a clear, practical, and engaging way.
We go beyond the headlines to explore what these advances actually mean in real life — for dermatologists, residents, and patients.
💡 In this episode, we discuss:
Why dermatology is shifting toward pathway-driven, precision medicine
The expanding role of JAK inhibitors across multiple diseases
New hope in alopecia areata — and why it’s more than “just hair loss”
Breakthrough momentum in vitiligo, including systemic treatment potential
Major progress in hidradenitis suppurativa and the move toward functional remission
The rise of oral therapies competing with biologics in psoriasis
Long-term disease control in atopic dermatitis, with less reliance on steroids
New options for chronic urticaria beyond antihistamines
The growing role of dermatologists as systemic disease specialists
🎧 About SkinScopeSkinScope is hosted by Dr Sandra Jerkovic Gulin and Dr George Kravvas, exploring skin health through science, evidence-based dermatology, and real-world clinical experience.
Podden och tillhörande omslagsbild på den här sidan tillhör
Sandra Jerkovic Gulin(@skindoc_sandra_jg) and George Kravvas(@drgeorgekravvas). Innehållet i podden är skapat av Sandra Jerkovic Gulin(@skindoc_sandra_jg) and George Kravvas(@drgeorgekravvas) och inte av,
eller tillsammans med, Poddtoppen.